Mary-Ann Etiebet, MD, MBA
AVP, Health Equity, Merck
Dr. Mary-Ann Etiebet has two decades of experience improving healthcare outcomes for underserved populations and transforming healthcare delivery at the frontlines. She serves as AVP for Health Equity at Merck and the Lead of Merck for Mothers*, Merck's $500M global health initiative to help create a world where no woman has to die giving life. Since 2011, Merck for Mothers programs and partnerships have resulted in healthy pregnancies and safe deliveries for over 13M women in 50 countries.
Building on her experiences as a physician, researcher, implementer, funder and advocate across the public, private and global development sectors, Dr. Etiebet brings a diverse set of perspectives to advancing health equity. She joined Merck in 2016 from Premier Inc, where she advanced health equity through population health management and value-based care initiatives. Previously, she served as an HIV physician and health system administrator leading quality improvement and community & care delivery transformation initiatives in the NYC public sector, a global public health practitioner leading PEPFAR supported clinical programs, and as Assistant Professor, in the Division of Infectious Disease at the University of Maryland School of Medicine.
Dr. Etiebet holds an MD and MBA from Yale University. She completed her residency in Internal Medicine at New York-Presbyterian Weill Cornell and fellowship in Infectious Diseases Hospital System at New York-Presbyterian Columbia University Medical Center, becoming Board Certified in both Internal Medicine and Infectious Diseases. She is a member of the Center for Global Development Board of Directors, the Board of Trustees of Vital Strategies, and the Advisory Committee for the Pozen-Commonwealth Fund Fellowship in Health Equity Leadership at Yale University. She also serves as the private sector representative on the World Health Organization (WHO) hosted Partnership for Maternal, Newborn & Child Health Board and the Investors Group of the World Bank’s Global Financing Facility.